NMRI.Cg-Tg(CMV-cre)1Nagy/Cnbc
Status | Available to order |
EMMA ID | EM:04372 |
International strain name | NMRI.Cg-Tg(CMV-cre)1Nagy/Cnbc |
Alternative name | CMV-cre |
Strain type | Transgenic Strains |
Allele/Transgene symbol | Tg(CMV-cre)1Nagy |
Gene/Transgene symbol | Tg(CMV-cre)1Nagy |
Information from provider
Provider | Andras Nagy |
Provider affiliation | Mount Sinai Hospital, Samuel Lunenfeld Research Institute |
Additional owner | Andras Nagy/Marina Gertsenstein are also distributing this line from CMMR, at TCP in Toronto. |
Genetic information | General deleter Cre line. Transgene expressing Cre recombinase under the control of human CMV promoter. The transgenic line (TgN(CMV-Cre)1AN) was created by pronuclear injection of the Cre-containing HindIII fragment of the pBS185 plasmid (Sauer B, Henderson N: Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase. New Biologist 1990, 2:441-449). |
Phenotypic information | Albino phenotype. |
Breeding history | Initially established by Andras Nagy's laboratory using ICR mouse background, transferred to CNB-CSIC in late '90s. Since then it was backcrossed to albino outbred NMRI (>10 generations) and bred to homozygosity. Currently existing as NMRI homozygous, viable and fertile. |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | CNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain |
Animals used for archiving | heterozygous NMRI, wild-type NMRI |
Stage of embryos | 2-cell |
Literature references
- Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles.;Nagy A, Moens C, Ivanyi E, Pawling J, Gertsenstein M, Hadjantonakis A K, Pirity M, Rossant J, ;1998;Current biology : CB;8;661-4; 9635194
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).